← Back
$TRDA All transactions

Entrada Therapeutics, Inc.

F

$ Value

$9K

Shares

1,746

Price

$5

Filed

Sep 4

Insider

Name

Dowden Nathan J

Title

President & COO

CIK

0001873392

Roles

Officer

Transaction Details

Transaction Date

2025-09-02

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

179,059

Footnotes

This sale represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of previously granted RSUs. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.36 to $5.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Filing Info

Accession No.

0001873392-25-000003

Form Type

4

Issuer CIK

0001689375

Dowden Nathan J's History

Date Ticker Type Value
2025-09-02 TRDA F $9K

Other Insiders at TRDA (90d)

Insider Bought Sold Last
WENTWORTH KORY JAMES
Chief Financial Officer
$32K 2026-04-01